CompletedNCT00249353
What is this study about?This study evaluated the safety and effectiveness of methylphenidate hydrochloride for people with ADHD.
This study has finished and is no longer accepting participants.
Location not clearly listedADHDMedication studyAges 13–18
- Countries
- Sponsor
- McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.
CompletedNCT01060150
Official study titleEfficacy and Learning Skill After OROS Methylphenidate Treatment in Adolescents With Attention-Deficit/Hyperactivity Disorder: A 12-week, Multi-center, Open-label Study
This study has finished and is no longer accepting participants.
Location not clearly listedADHDMedication studyAges 12–18
- Countries
- Sponsor
- Janssen Korea, Ltd., Korea
CompletedNCT04167995
Official study titleAssessment of Probiotic Strain Lactobacillus Acidophilus LB Supplementation as Adjunctive Management of Attention-deficit Hyperactivity Disorder in Children and Adolescents: a Randomized Controlled Clinical Trial
This study has finished and is no longer accepting participants.
In CairoADHDMedication studyAges 6–16
- Countries
- Egypt
- Sponsor
- Ain Shams University
CompletedNCT00254462
Official study titlePharmacological Treatment of ADHD in Young Children
This study has finished and is no longer accepting participants.
Multiple locations, including OmahaADHDMedication studyAges 5–6
- Countries
- United States
- Sponsor
- University of Nebraska
CompletedNCT00142961
What is this study about?Researchers compared atomoxetine and placebo to find out how the approaches affected ADHD symptoms in people with ADHD.
This study has finished and is no longer accepting participants.
In New YorkADHDMedication studyAges 14–21
- Countries
- United States
- Sponsor
- New York State Psychiatric Institute
CompletedNCT00380692
What is this study about?Researchers compared atomoxetine and placebo to find out how the approaches affected ADHD symptoms in children and adolescents with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including AmsterdamADHDMedication studyAges 6–17
- Countries
- Netherlands
- Sponsor
- Eli Lilly and Company
TerminatedNCT00684931
Official study titleAlterations of Fronto-Cerebello-Frontal Loops in Attention Deficit Hyperactivity Disorder (ADHD) : A Study Using Magnetic Resonance Imaging (MRI)
This study ended early.
In BordeauxADHDInterventional studyAges 18–35
- Countries
- France
- Sponsor
- University Hospital, Bordeaux
CompletedNCT01260792
Official study titleValidation and Norms for Attention Deficit/Hyperactivity Disorder Scales in Children and Adults. Description of Associated Factors.
This study has finished and is no longer accepting participants.
In NiceADHDObservational studyAges 5–18
- Countries
- France
- Sponsor
- Centre Hospitalier Universitaire de Nice
CompletedNCT00830700
Official study titleTelemental Health to Improve Mental Health Care and Outcomes for Children in Underserved Areas
This study has finished and is no longer accepting participants.
In SeattleADHDInterventional studyAges 5–12
- Countries
- United States
- Sponsor
- Seattle Children's Hospital
CompletedNCT00550667
This study has finished and is no longer accepting participants.
In TaipeiADHDObservational studyAges 18–45
- Countries
- Taiwan
- Sponsor
- National Taiwan University Hospital
CompletedNCT00031395
Official study titleClonidine in Attention Deficit Hyperactivity Disorder (ADHD) Treatment (CAT)
This study has finished and is no longer accepting participants.
Multiple locations, including BuffaloADHDMedication studyAges 7–12
- Countries
- United States
- Sponsor
- University of Cincinnati
CompletedNCT02937142
Official study titleCognitive Behavior Group Therapy in Adolescents (14-18 Years) With Attention Deficit Hyperactivity Disorder (ADHD)
This study has finished and is no longer accepting participants.
In TrondheimADHDBehavioural studyAges 14–18
- Countries
- Norway
- Sponsor
- St. Olavs Hospital